BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 32042139)

  • 1. Diagnostic imaging of cardiac amyloidosis.
    Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
    Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac amyloidosis.
    Martinez-Naharro A; Hawkins PN; Fontana M
    Clin Med (Lond); 2018 Apr; 18(Suppl 2):s30-s35. PubMed ID: 29700090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.
    Aljaroudi WA; Desai MY; Tang WH; Phelan D; Cerqueira MD; Jaber WA
    J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
    Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality imaging in cardiac amyloidosis: a primer for cardiologists.
    Jurcuţ R; Onciul S; Adam R; Stan C; Coriu D; Rapezzi C; Popescu BA
    Eur Heart J Cardiovasc Imaging; 2020 Aug; 21(8):833-844. PubMed ID: 32393965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
    Brownrigg J; Lorenzini M; Lumley M; Elliott P
    ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
    Martini N; Rizzo S; Sarais C; Cipriani A
    BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
    Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
    Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
    Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
    Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal Imaging and Biomarkers in Cardiac Amyloidosis.
    Jung MH; Chang S; Han EJ; Youn JC
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and typing of cardiac amyloidosis by noninvasive imaging: Two cases for two patterns.
    Nappi C; Zampella E; Volpe F; De Risi M; Piscopo L; Ponsiglione A; Imbriaco M; Acampa W; Petretta M; Cuocolo A
    J Nucl Cardiol; 2020 Jun; 27(3):915-920. PubMed ID: 31845305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and Diagnosis of Cardiac Amyloidosis in Egypt.
    Abdelghany M; Abdelhamid M; Allam A; El Etriby A; Hafez S; Ragy H; Sobhy M
    Cardiol Ther; 2023 Mar; 12(1):197-213. PubMed ID: 36611101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac manifestations of amyloid disease.
    Rivera RJ; Vicenty S
    Bol Asoc Med P R; 2008; 100(4):60-70. PubMed ID: 19400531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging in systemic amyloidosis.
    Sachchithanantham S; Wechalekar AD
    Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.
    Korosoglou G; Giusca S; André F; Aus dem Siepen F; Nunninger P; Kristen AV; Frey N
    Vasc Health Risk Manag; 2021; 17():661-673. PubMed ID: 34720583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light chain cardiac amyloidosis - a rare cause of heart failure in a young adult.
    Domingues K; Saraiva M; Marta L; Monteiro I; Leal M
    Rev Assoc Med Bras (1992); 2018 Sep; 64(9):787-790. PubMed ID: 30672998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in PET-Based Cardiac Amyloid Radiotracers.
    Gallegos C; Miller EJ
    Curr Cardiol Rep; 2020 May; 22(6):40. PubMed ID: 32430600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.